HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Xu Selected Research

albiflorin

1/2019Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome.
9/2012Screening for the efficacy on lipid accumulation in 3T3-L1 cells is an effective tool for the identification of new anti-diabetic compounds.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Xu Research Topics

Disease

245Neoplasms (Cancer)
06/2022 - 11/2004
58Inflammation (Inflammations)
06/2022 - 03/2002
55Infections
04/2022 - 08/2002
37Neoplasm Metastasis (Metastasis)
07/2022 - 08/2002
35Lung Neoplasms (Lung Cancer)
01/2022 - 10/2004
33Hepatocellular Carcinoma (Hepatoma)
09/2022 - 08/2002
33Alzheimer Disease (Alzheimer's Disease)
03/2022 - 01/2009
32Fibrosis (Cirrhosis)
04/2022 - 08/2002
21Breast Neoplasms (Breast Cancer)
01/2022 - 03/2011
20Wounds and Injuries (Trauma)
06/2022 - 01/2002
20Stomach Neoplasms (Stomach Cancer)
06/2022 - 03/2006
20Pain (Aches)
01/2022 - 08/2006
20Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2002
20Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 02/2009
19Hypoxia (Hypoxemia)
11/2022 - 04/2010
19Type 2 Diabetes Mellitus (MODY)
10/2021 - 01/2011
17Carcinogenesis
01/2022 - 04/2012
16Pancreatitis
04/2020 - 05/2003
15Osteoporosis
12/2021 - 12/2013
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 05/2008
14Leukemia
01/2022 - 04/2013
13Ischemia
02/2021 - 01/2003
13Carcinoma (Carcinomatosis)
02/2020 - 05/2002
12Liver Diseases (Liver Disease)
06/2022 - 10/2008
12Sepsis (Septicemia)
06/2022 - 11/2009
12Infarction (Infarctions)
04/2022 - 01/2012
12Insulin Resistance
01/2022 - 04/2003
12Hemorrhage
01/2022 - 08/2007
12Myocardial Infarction
01/2022 - 01/2012
12Necrosis
01/2019 - 09/2004
11Pneumonia (Pneumonitis)
01/2022 - 08/2002
11Obesity
01/2022 - 09/2011
10Melanoma (Melanoma, Malignant)
03/2022 - 01/2016
10Prostatic Neoplasms (Prostate Cancer)
01/2022 - 12/2007
10Liver Neoplasms (Liver Cancer)
11/2021 - 08/2002
10Non-alcoholic Fatty Liver Disease
10/2021 - 09/2014
9Body Weight (Weight, Body)
01/2022 - 04/2003
9Virus Diseases (Viral Diseases)
01/2022 - 09/2005
9Dehydration (Water Stress)
12/2021 - 03/2012
9Heart Arrest (Cardiac Arrest)
10/2021 - 03/2015
9Cicatrix (Scar)
01/2020 - 09/2002
8Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2015
8Cognitive Dysfunction
12/2021 - 01/2015
8Bone Resorption
08/2020 - 04/2010
8Reperfusion Injury
01/2017 - 01/2003
7Neuroinflammatory Diseases
11/2022 - 04/2013
7COVID-19
01/2022 - 01/2020
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 03/2016
7Ventricular Fibrillation
01/2022 - 01/2015
7Dysbiosis
01/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

84Proteins (Proteins, Gene)FDA Link
11/2022 - 02/2004
44Pharmaceutical PreparationsIBA
01/2022 - 04/2005
34Biomarkers (Surrogate Marker)IBA
06/2022 - 12/2007
30Glucose (Dextrose)FDA LinkGeneric
05/2022 - 04/2003
29Biological ProductsIBA
04/2022 - 03/2012
26Messenger RNA (mRNA)IBA
01/2021 - 01/2003
24MicroRNAs (MicroRNA)IBA
01/2022 - 11/2008
23Therapeutic UsesIBA
01/2022 - 01/2002
21Small Interfering RNA (siRNA)IBA
09/2021 - 03/2004
21CytokinesIBA
08/2021 - 08/2002
17Long Noncoding RNAIBA
09/2022 - 05/2016
17LipidsIBA
01/2022 - 04/2006
17AntigensIBA
08/2021 - 02/2011
16DNA (Deoxyribonucleic Acid)IBA
10/2021 - 09/2006
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2019 - 11/2004
15EnzymesIBA
01/2021 - 03/2005
14Insulin (Novolin)FDA Link
10/2021 - 01/2009
13Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 07/2013
13RNA (Ribonucleic Acid)IBA
01/2022 - 05/2012
11CateninsIBA
09/2022 - 09/2013
11Oxygen (Dioxygen)IBA
01/2022 - 06/2005
11Chimeric Antigen ReceptorsIBA
01/2022 - 01/2015
11Coal (Coals)IBA
12/2021 - 11/2013
10Antiviral Agents (Antivirals)IBA
01/2022 - 06/2008
10Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
10LigandsIBA
01/2022 - 11/2004
10Phosphotransferases (Kinase)IBA
07/2021 - 10/2012
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2015 - 01/2003
9Indicators and Reagents (Reagents)IBA
01/2022 - 12/2005
9Circular RNAIBA
12/2021 - 01/2019
9fu-yuanIBA
12/2021 - 01/2014
9Cisplatin (Platino)FDA LinkGeneric
01/2021 - 02/2005
9Histones (Histone)IBA
03/2020 - 11/2009
8LipopolysaccharidesIBA
06/2022 - 06/2008
8AntibodiesIBA
01/2022 - 07/2004
8CarcinogensIBA
10/2021 - 05/2015
8Peptides (Polypeptides)IBA
09/2021 - 06/2005
8Eosine Yellowish-(YS) (Eosin)IBA
03/2021 - 07/2010
8AntioxidantsIBA
10/2019 - 02/2015
7CollagenIBA
01/2022 - 03/2012
7Bile Acids and Salts (Bile Acids)IBA
01/2022 - 09/2014

Therapy/Procedure

121Therapeutics
06/2022 - 05/2003
33Drug Therapy (Chemotherapy)
01/2022 - 02/2005
30Immunotherapy
06/2022 - 08/2011
16Cardiopulmonary Resuscitation (CPR)
01/2022 - 03/2015
13Radiotherapy
06/2022 - 05/2006
13Transplantation
01/2022 - 02/2011
10Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2020 - 01/2010
9Length of Stay
08/2021 - 08/2004
9Ligation
01/2018 - 11/2009